OBI vs. NSCI, DEST, ONC, SBTX, OPTI, SNG, HEMO, BVX, IMM, and GENF
Should you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include NetScientific (NSCI), Destiny Pharma (DEST), Oncimmune (ONC), SkinBioTherapeutics (SBTX), OptiBiotix Health (OPTI), Synairgen (SNG), Hemogenyx Pharmaceuticals (HEMO), BiVictriX Therapeutics (BVX), ImmuPharma (IMM), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.
NetScientific (LON:NSCI) and Ondine Biomedical (LON:OBI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, profitability, institutional ownership, valuation, risk, dividends and media sentiment.
NetScientific received 70 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 69.61% of users gave NetScientific an outperform vote.
4.3% of NetScientific shares are owned by institutional investors. Comparatively, 7.5% of Ondine Biomedical shares are owned by institutional investors. 40.0% of NetScientific shares are owned by company insiders. Comparatively, 50.0% of Ondine Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, NetScientific had 1 more articles in the media than Ondine Biomedical. MarketBeat recorded 1 mentions for NetScientific and 0 mentions for Ondine Biomedical. Ondine Biomedical's average media sentiment score of 0.00 equaled NetScientific'saverage media sentiment score.
Ondine Biomedical has a net margin of 0.00% compared to Ondine Biomedical's net margin of -221.55%. Ondine Biomedical's return on equity of -21.43% beat NetScientific's return on equity.
NetScientific has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Comparatively, Ondine Biomedical has a beta of -0.01, indicating that its stock price is 101% less volatile than the S&P 500.
NetScientific has higher revenue and earnings than Ondine Biomedical. NetScientific is trading at a lower price-to-earnings ratio than Ondine Biomedical, indicating that it is currently the more affordable of the two stocks.
Summary
NetScientific and Ondine Biomedical tied by winning 7 of the 14 factors compared between the two stocks.
Get Ondine Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ondine Biomedical Competitors List
Related Companies and Tools
